This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Developers at the Chinese University of Hong Kong claim it "communicates like a ...
Its digital marketplace, featuring over a million products, seeks to address iss...
Rounding off a turbulent few years, genetic testing company 23andMe is filing fo...
When cold and flu season intensifies, calls to healthcare contact centers surge....
Augustine Therapeutics has reeled in €77.7 million (about $85 million) to take o...
Our mental health system is not designed to treat people in crisis. Instead of b...
Also, a new AI model potentially enhances endometrial cancer diagnosis by achiev...
Also, two Korean digital dentistry solutions provider are integrating AI into th...
Hospitals started 2025 with a stable financial performance driven by strong pati...
An expanded partnership with Humana will help Aledade’s FQHC and rural health cl...
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But...
Creating adequate capacity for any therapeutic can be challenging, and the speci...
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This articl...
State, federal, and academic initiatives have poured time and resources into und...
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...
Hello and welcome back to the new Endpoints Weekly. It was another busy week in ...